HBPCF

Helix BioPharma Corp.

HealthcareBiotechnologyCAUSDPeers →via fmp_bulkCountry macro →

$1.71

LiveJun 05, 2026

AI Brief

Market cap

$130.61M

52w range

0.60 – 1.73

P / E

—

EPS

—

Volume

Revenue · FY

—

Overview Profile Ratios Multiples Themes Earnings Prices Sentiment ESG

Explain this page

Arphra AIPlain-English read on Helix BioPharma Corp.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1.71

Change

-1.16%

Period high

$1.73

Period low

$1.71

Period start

$1.732026-02-02

Through 2026-06-05

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
0.00%	0.00%	-1.16%	-1.16%	-1.16%	-1.16%	+185.00%	+135.86%	-55.81%	-73.77%	-83.94%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 05, 08:00 PM

Last trade

$1.71

Bid

$1.71

0 sh

Ask

$1.73

4,350 sh

Spread

$0.020

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.92%
Consumer Cyclical
+1.74%
Consumer Defensive
+1.68%
Financial Services
+0.35%
Communication Services
+0.32%
Industrials
+0.19%
Basic Materials
+0.07%
Healthcare
-0.22%
Utilities
-0.26%
Energy
-1.14%
Technology
-1.59%

Top industries (issuer's industry highlighted)

Biotechnology
+2.80%
Solar
-7.33%
Furnishings, Fixtures & Appliances
+5.13%
Investment - Banking & Investment Services
-4.94%
Computer Hardware
-4.91%
Medical - Equipment & Services
+3.95%
Silver
-3.66%
Financial - Mortgages
+3.52%
Hardware, Equipment & Parts
-3.36%
Home Improvement
+3.35%
Software - Infrastructure
-3.30%
Apparel - Manufacturers
+3.21%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for HBPCF.

Peers

No peer list available for HBPCF.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin